These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17539698)

  • 1. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 4():34-9. PubMed ID: 17539698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
    Monteleone P; Martiadis V; Maj M
    Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight gain with atypical antipsychotics: evidence and insights.
    Henderson DC
    J Clin Psychiatry; 2007; 68 Suppl 12():18-26. PubMed ID: 17956152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic risk during antipsychotic treatment.
    Newcomer JW
    Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.
    Weiden PJ; Buckley PF
    J Clin Psychiatry; 2007; 68 Suppl 6():14-23. PubMed ID: 17650055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching in the era of atypical antipsychotics. An updated review.
    Weiden PJ
    Postgrad Med; 2006 Sep; Spec No():27-44. PubMed ID: 17128659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
    Huang TL; Lu CY
    Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight gain associated with use of psychotropic medications.
    Sachs GS; Guille C
    J Clin Psychiatry; 1999; 60 Suppl 21():16-9. PubMed ID: 10548137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical antipsychotic induced weight gain and metabolic disorders].
    Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
    Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric medication-induced obesity: a review.
    Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
    Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric medication induced obesity: an aetiologic review.
    Virk S; Schwartz TL; Jindal S; Nihalani N; Jones N
    Obes Rev; 2004 Aug; 5(3):167-70. PubMed ID: 15245385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.